﻿<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
	<title>FDA Center for Drug Evaluation and Research - What's New</title>
	<description>What's New at CDER</description>
	<link>http://www.fda.gov/cder/whatsnew.htm</link>
	<language>en-us</language>
	<lastBuildDate>Tue, 26 May 2009 10:55 EDT</lastBuildDate>
	<webMaster>cderwebmaster@fda.hhs.gov (CDER Webmaster)</webMaster>

<item>
<title>Drug Shortages: Current Drug Shortages: Technetium Tc99m Generators (updated)</title>
  <description>Current Drug Shortages: Technetium Tc99m Generators, See letter in Related Information Section</description>
  <pubDate>Tue, 26 May 2009 10:55 EST</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#technetium</link>
</item>
<item>
  <title>Guidance for Industry</title> 
  <description>Guidance for Industry: Presenting Risk Information in Prescription Drug and Medical Device Promotion</description> 
  <pubDate>Tue, 26 May 2009 07:45 EDT</pubDate> 
  <link>http://www.fda.gov/cder/guidance/7427dft.pdf</link> 
</item>
<item>
  <title>Agenda for the May 27 - 28, 2009 Opioid REMS Public Meeting</title> 
  <description>Agenda for the May 27 - 28, 2009 Opioid REMS Public Meeting</description> 
  <pubDate>Fri, 22 May 2009 12:35 EDT</pubDate> 
  <link>http://www.fda.gov/cder/meeting/opioid/OpioidREMSPublicMeetingFinalAgenda.pdf</link> 
</item>
<item>
<title>Drug Shortages: Current Drug Shortages: Technetium Tc99m Generators</title>
  <description>Current Drug Shortages: Technetium Tc99m Generators, Reduced supply due to material sourcing issues, Covidien: 
1-888-744-1414 (Ultra-Technekow DTE, NDA 17-243) and Lantheus: 1-800-299-3431 (Technelite, NDA 17-771)</description>
  <pubDate>Thu, 21 May 2009 13:35 EST</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#technetium</link>
</item>
<item>
<title>Drugs@FDA Downloadable Data Files (updated)</title> 
 <description>Drugs@FDA Downloadable Data Files</description> 
 <pubDate>Wed, 20 May 2009 15:15 EDT</pubDate> 
 <link>http://www.fda.gov/cder/drugsatfda/datafiles/default.htm</link> 
 </item> 
<item>
<title>Drug Shortages: Current Drug Shortages: Morphine Sulfate Oral Solution (updated)</title>
  <description>Current Drug Shortages: Morphine Sulfate Oral Solution, See updated Dear Healthcare Provider Letter in the Related Information section</description>
  <pubDate>Wed, 20 May 2009 10:00 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Morphine</link>
</item>
<item>
   <title>Paragraph IV Patent Certifications</title>
   <description>Office of Generic Drugs: Paragraph IV Patent Certifications (updated)</description>
   <pubDate>Tue, 19 May 2009 15:05 EDT</pubDate>
   <link>http://www.fda.gov/cder/ogd/ppiv.htm</link>
</item>
<item>
<title>Drug Shortages: Current Drug Shortages: Isoniazid Injection (NDC 00781-3056-70)</title>
  <description>Current Drug Shortages: Isoniazid Injection (NDC 00781-3056-70), Product continues to be available with short expiration dating, Sandoz has continued to make isoniazid injection available and the product may be ordered through wholesalers, Sandoz (customer service number) 1-800-525-8747</description>
  <pubDate>Tue, 19 May 2009 13:50 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Isoniazid</link>
</item>
<item>
<title>Drug Shortages: Resolved Drug Shortages: Enlon (edrophonium chloride) injection and Enlon Plus (edrophonium chloride and atropine sulfate) injection (updated)</title>
  <description>Resolved Drug Shortages: Enlon (edrophonium chloride) injection and Enlon Plus (edrophonium chloride and atropine sulfate) injection, See Company Information for updated contact information</description>
  <pubDate>Tue, 19 May 2009 13:40 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Enlon</link>
</item>
<item>
<title>Manual of Policies and Procedures</title>
  <description>Review and Conduct of Human Subject Research</description>
  <pubDate>Tue, 19 May 2009 10:55 EDT</pubDate>
  <link>http://www.fda.gov/cder/mapp/7700.2.pdf</link>
</item>
<item>
<title>Guidance for Industry</title>
  <description>Formal Meetings Between the FDA and Sponsors or Applicants</description>
  <pubDate>Tue, 19 May 2009 10:43 EDT</pubDate>
  <link>http://www.fda.gov/cder/guidance/7476fnl.pdf</link>
</item>
<item>
<title>Adverse Event Reporting System (AERS) Statistics (updated)</title>
  <description>Adverse Event Reporting System (AERS) Statistics (updated)</description>
  <pubDate>Mon, 18 May 2009 18:10 EDT</pubDate>
  <link>http://www.fda.gov/cder/aers/statistics/default.htm</link>
</item>
<item>
<title>Drug Shortages: Current Drug Shortages: Methotrexate injection (updated)</title>
  <description>Current Drug Shortages: Methotrexate injection, Ebewe Parenta Pharmaceuticals, Inc. 
(1-800-898-9948) is now accepting orders for preservative-free methotrexate injection and shipment is planned for the first week of June.</description>
  <pubDate>Mon, 18 May 2009 11:30 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Methotrexate</link>
</item>
<item>
<title>Drug Shortages: Resolved Drug Shortages: Enlon (edrophonium chloride) injection and Enlon Plus (edrophonium chloride and atropine sulfate) injection</title>
  <description>Resolved Drug Shortages: Enlon (edrophonium chloride) injection and Enlon Plus (edrophonium chloride and atropine sulfate) injection, Bioniche Pharma has available the Enlon Plus 5 mL ampule (NDC 67457-0192-05) and the Enlon (NDC 67457-0190-15). The Enlon Plus multi- dose vials (NDC 67457-0191-15) are anticipated to be available soon.</description>
  <pubDate>Mon, 18 May 2009 11:30 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Enlon</link>
</item>
<item>
<title>Drug Shortages: Current Drug Shortages: Dexrazoxane for Injection, Zinecard</title>
  <description>Current Drug Shortages: Dexrazoxane for Injection, Zinecard, Manufacturing delays, Totect remains in limited availability, labeled for use in treatment of extravasation resulting from IV anthracycline chemotherapy. TopoTarget inquiries:
1-866-470-8247</description>
  <pubDate>Fri, 15 May 2009 07:10 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Dexrazoxane</link>
</item>
<item>
<title>Drug Shortages: Current Drug Shortages: Oxycodone Immediate Release Tablets (5mg, 15mg and 30mg) (updated)</title>
  <description>Current Drug Shortages: Oxycodone Immediate Release Tablets (5mg, 15mg and 30mg), See website for updated information</description>
  <pubDate>Thu, 14 May 2009 12:00 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Oxycodone</link>
</item>
<item>
<title>Memorandum of Meeting Minutes: Drug Safety Oversight Board Meetings</title>
  <description>Drug Safety Oversight Board Meetings: Public Summaries, April 16, 2009</description>
  <pubDate>Wed, 13 May 2009 10:45 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/DrugSafety/DSOBmeetings/DSOB20090416.htm</link>
</item>
<item>
<title>Drug Shortages: Resolved Drug Shortages: Fentanyl transdermal patch (updated)</title>
  <description>Resolved Drug Shortages: Fentanyl transdermal patch, See update in Company name for Teva, in the Related Information section</description>
  <pubDate>Wed, 13 May 2009 09:55 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Fentanyl</link>
</item>
<item>
  <title>BPCA of 2007: List of Determinations including Written Request</title> 
  <description>Best Pharmaceuticals for Children Act of 2007: List of Determinations Including Written Request (updated)</description> 
  <pubDate>Wed, 13 May 2009 06:50 EDT</pubDate> 
  <link>http://www.fda.gov/cder/pediatric/bpca_determination.htm</link> 
  </item>
<item>
<title>April First-Time Generic Drug Approvals</title>
  <description>Office of Generic Drugs: April First-Time Generic Drug Approvals</description>
  <pubDate>Wed, 13 May 2009 06:50 EDT</pubDate>
  <link>http://www.fda.gov/cder/ogd/approvals/default.htm</link>
</item>
<item>
<title>Guidance for Industry</title>
  <description>Labeling OTC Human Drug Products; Small Entity Compliance Guide</description>
  <pubDate>Tue, 12 May 2009 11:35 EDT</pubDate>
  <link>http://www.fda.gov/cder/guidance/6920fnl.pdf</link>
</item>
<item>
<title>Drug Shortages: Current Drug Shortages: Oxycodone Immediate Release Tablets (5mg, 15mg and 30mg) (updated)</title>
  <description>Current Drug Shortages: Oxycodone Immediate Release Tablets (5mg, 15mg and 30mg), See updated Company Information section on Xanodyne Pharmaceuticals, Inc</description>
  <pubDate>Mon, 11 May 2009 11:20 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Oxycodone</link>
</item>
<item>
<title>Drug Shortages: Current Drug Shortages: Cisplatin Injection 1mg/ml (updated)</title>
  <description>Current Drug Shortages: Cisplatin Injection 1mg/ml : See updated Related Information Section for Teva</description>
  <pubDate>Mon, 11 May 2009 10:40 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Cisplatin</link>
</item>
<item>
  <title>BPCA of 2007: List of Determinations including Written Request</title> 
  <description>Best Pharmaceuticals for Children Act of 2007: List of Determinations Including Written Request (updated)</description> 
  <pubDate>Mon, 11 May 2009 09:50 EDT</pubDate> 
  <link>http://www.fda.gov/cder/pediatric/bpca_determination.htm</link> 
  </item>
<item>
<title>BPCA/Pediatric Exclusivity Statistics</title>
    <description>BPCA/Pediatric Exclusivity Statistics (updated)</description>
    <pubDate>Mon, 11 May 2009 09:50 EDT</pubDate>
    <link>http://www.fda.gov/cder/pediatric/index.htm</link>
</item>
<item>	
	<title>Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies</title>
	 <description>Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505A and 505B of the FDA (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA)</description>
	<pubDate>Mon, 11 May 2009 09:50 EDT</pubDate>
	<link>http://www.fda.gov/cder/pediatric/BpcaPrea_full_review.htm</link>
</item>
<item>
<title>CDER Organization Charts</title>
    <description>CDER Organization Charts (updated)</description>
	<pubDate>Fri, 08 May 2009 15:50 EDT</pubDate>
	<link>http://www.fda.gov/cder/cderorg.htm</link>
</item>
<item>
<title>PDUFA update</title>
  <description>The Dear Colleague Letter, in anticipation of FY 2010 Invoices, was mailed Tuesday, May 5, 2009</description>
  <pubDate>Fri, 08 May 2009 09:40 EDT</pubDate>
  <link>http://www.fda.gov/cder/pdufa/letters.htm</link>
</item>
<item>
<title>Drug Shortages: Current Drug Shortages: Mitomycin for injection (updated)</title>
  <description>Current Drug Shortages: Mitomycin for injection: See updated Related Information Section</description>
  <pubDate>Fri, 08 May 2009 09:40 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Mitomycin</link>
</item>
<item>
<title>Testosterone Gel Safety Information</title>
  <description>Testosterone Gel Safety Concerns Prompt FDA to Require Label Changes, Medication Guide
</description>
  <pubDate>Fri, 08 May 2009 08:50 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/infopage/testosterone_gel/default.htm</link>
</item>
<item>
<title>Guidance for Industry</title>
  <description>Comprehensive List of Guidance Documents</description>
  <pubDate>Thu, 07 May 2009 12:40 EDT</pubDate>
  <link>http://www.fda.gov/cder/guidance/CompList200904.pdf</link>
</item>
<item>
<title>Guidance for Industry</title>
  <description>New Revised/Withdrawn List for 2009</description>
  <pubDate>Thu, 07 May 2009 12:40 EDT</pubDate>
  <link>http://www.fda.gov/cder/guidance/newrevwd200904.pdf</link>
</item>
<item>
<title>Drug Shortages: Current Drug Shortages: Metoprolol succinate extended release tablets (updated)</title>
  <description>Current Drug Shortages: Metoprolol succinate extended release tablets: See updated letter in Related Information Section</description>
  <pubDate>Thu, 07 May 2009 10:40 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#metoprolol</link>
</item>
<item>
<title>Drug Shortages: Current Drug Shortages: Mitomycin for injection (updated)</title>
  <description>Current Drug Shortages: Mitomycin for injection:  Ben Venue is shipping product, with allocation in effect, customer service: 1-800-562-4797</description>
  <pubDate>Thu, 07 May 2009 10:40 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Mitomycin</link>
</item>
<item>
  <title>Risk Evaluation and Mitigation Strategy (REMS) Under Review for CellCept and Myfortic </title>
  <description>BRisk Evaluation and Mitigation Strategy (REMS) Under Review for CellCept and Myfortic </description>
  <pubDate>Wed, 06 May 2009 15:10 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/infopage/mycophenolate/REMS.htm</link>
</item>
<item>
  <title>Pediatric Exclusivity Granted</title>
  <description>BPCA/Pediatric Exclusivity Statistics: Pediatric Exclusivity Granted (updated)</description>
  <pubDate>Wed, 06 May 2009 08:00 EDT</pubDate>
  <link>http://www.fda.gov/cder/pediatric/exgrant.htm</link>
</item>
<item>
   <title>Paragraph IV Patent Certifications</title>
   <description>Office of Generic Drugs: Paragraph IV Patent Certifications (updated)</description>
   <pubDate>Mon, 04 May 2009 14:45 EDT</pubDate>
   <link>http://www.fda.gov/cder/ogd/ppiv.htm</link>
</item>
<item>
<title>Division of Drug Marketing, Advertising, and Communications: Presentations</title> 
 <description>Division of Drug Marketing, Advertising, and Communications: Presentations (updated)</description> 
 <pubDate>Mon, 04 May 2009 13:20 EDT</pubDate> 
 <link>http://www.fda.gov/cder/ddmac/presentations.htm</link> 
 </item> 

<item>
<title>Drugs@FDA Downloadable Data Files (updated)</title> 
 <description>Drugs@FDA Downloadable Data Files (updated)</description> 
 <pubDate>Fri, 01 May 2009 14:15 EDT</pubDate> 
 <link>http://www.fda.gov/cder/drugsatfda/datafiles/default.htm</link> 
 </item> 
<item>
  <title>FDA has approved pancrelipase (Creon Delayed-Release Capsules)</title> 
  <description>FDA has approved pancrelipase (Creon Delayed-Release Capsules) for adult and pediatric patients with exocrine pancreatic insufficiency</description> 
  <pubDate>Fri, 01 May 2009 14:00 EDT</pubDate> 
  <link>http://www.fda.gov/cder/drug/infopage/pancrelipase/default.htm</link> 
  </item>
  <item>
  <title>Rulemaking History for Nonprescription Products</title> 
  <description>Office of Nonprescription Products: Rulemaking History for Nonprescription Products (updated)</description> 
  <pubDate>Fri, 01 May 2009 09:20 EDT</pubDate> 
  <link>http://www.fda.gov/cder/otcmonographs/rulemaking_index.htm</link> 
  </item>
<item>
<title>Drug Shortages: Current Drug Shortages: Methotrexate injection</title>
  <description>Current Drug Shortages: Methotrexate injection:  Bedford Laboratories- manufacturing delays, Hospira- unable to meet demand, GeneraMedix- increase in demand and APP has product available. See Related Information section for more information</description>
  <pubDate>Thu, 30 Apr 2009 14:20 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Methotrexate</link>
</item>
<item>
<title>FDA updates the Early Communication about an Ongoing Safety Review of Botox and Botox Cosmetic and Myobloc</title>
  <description>FDA updates the Early Communication about an Ongoing Safety Review of Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B)</description>
  <pubDate>Thu, 30 Apr 2009 13:50 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/early_comm/botulinium_toxins200904.htm</link>
</item>
<item>
<title>Guidance for Industry</title>
  <description>Label Comprehension Studies for Nonprescription Drug Products</description>
  <pubDate>Thu, 30 Apr 2009 08:00 EDT</pubDate>
  <link>http://www.fda.gov/cder/guidance/2925dft.pdf</link>
</item>
<item>
<title>Guidance for Industry</title>
  <description>Individual Product Bioequivalence Recommendations</description>
  <pubDate>Wed, 29 Apr 2009 16:18 EDT</pubDate>
  <link>http://www.fda.gov/cder/guidance/bioequivalence/default.htm</link>
</item>
<item>
<title>Manual of Policies and Procedures (MaPP)</title>
  <description>Scientific Interest Groups: Criteria and Policies</description>
  <pubDate>Tue, 28 Apr 2009 16:10 EDT</pubDate>
  <link>http://www.fda.gov/cder/mapp/5100.4.pdf</link>
</item>
<item>
<title>Drug Shortages: Current Drug Shortages: Morphine Sulfate Oral Solution (updated)</title>
  <description>Current Drug Shortages: Morphine Sulfate Oral Solution, Roxane- has product available. See information in Related Information section, Mallinckrodt- Increased demand due to another manufacturer leaving the market, Lannett-Increased demand due to another manufacturer leaving the market, and Glenmark- Increased demand due to another manufacturer leaving the market</description>
  <pubDate>Tue, 28 Apr 2009 16:00 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Morphine</link>
</item>
<item>
<title>Drug Shortages: Resolved Drug Shortages: Levoleucovorin (Fusilev) 50 mg single use vials</title>
  <description>Resolved Drug Shortages: Levoleucovorin (Fusilev) 50 mg single use vials, see Related Information Section</description>
  <pubDate>Mon, 27 Apr 2009 11:35 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Levoleucovorin</link>
</item>
<item>
<title>Drug Shortages: Resolved Drug Shortages: Leucovorin Calcium Solution for Injection</title>
  <description>Resolved Drug Shortages: Leucovorin Calcium Solution for Injection, see Related Information Section</description>
  <pubDate>Mon, 27 Apr 2009 11:35 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Leucovorin</link>
</item>
<item>
<title>Drugs@FDA Downloadable Data Files (updated)</title> 
 <description>Drugs@FDA Downloadable Data Files (updated)</description> 
 <pubDate>Thu, 23 Apr 2009 16:00 EDT</pubDate> 
 <link>http://www.fda.gov/cder/drugsatfda/datafiles/default.htm</link> 
 </item> 
 <item>	
	<title>Approved Drug Products with Therapeutic Equivalence Evaluations Orange Book </title>
	 <description>Approved Drug Products with Therapeutic Equivalence Evaluations Orange Book </description>
	<pubDate>Thu, 23 Apr 2009 14:55 EDT</pubDate>
	<link>http://www.fda.gov/cder/orange/default.htm</link>
</item>	
 <item>	
	<title>FDA updates action on Plan B (levonorgestrel) tablets</title>
	 <description>FDA updates action on Plan B (levonorgestrel) tablets</description>
	<pubDate>Thu, 23 Apr 2009 14:55 EDT</pubDate>
	<link>http://www.fda.gov/bbs/topics/NEWS/2009/NEW01999.html</link>
</item>	
<item>	
	<title>Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies</title>
	 <description>Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conductedf under Section 505A and 505B of the FDA (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA)</description>
	<pubDate>Thu, 23 Apr 2009 14:55 EDT</pubDate>
	<link>http://www.fda.gov/cder/pediatric/BpcaPrea_full_review.htm</link>
</item>	
<item>
<title>Drug Shortages: Current Drug Shortages: Metoprolol succinate extended release tablets</title>
  <description>Current Drug Shortages: Metoprolol succinate extended release tablets, see updated letter in Related Information Section</description>
  <pubDate>Mon, 20 Apr 2009 15:55 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#metoprolol</link>
</item>
<item>
<title>Drug Shortages: Resolved Drug Shortages: Acyclovir Injection</title>
  <description>Resolved Drug Shortages: Acyclovir Injection, APP currently has all presentations available and Bedford currently reports available product for drop shipment</description>
  <pubDate>Mon, 20 Apr 2009 15:55 EDT</pubDate>
  <link>http://www.fda.gov/cder/drug/shortages/default.htm#Acyclovir</link>
</item>
<item>	
	<title>Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies</title>
	 <description>Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505A and 505B of the FDA (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA)</description>
	<pubDate>Mon, 20 Apr 2009 15:00 EDT</pubDate>
	<link>http://www.fda.gov/cder/pediatric/BpcaPrea_full_review.htm</link>
</item>	
<item>
   <title>Guidance for Industry</title>
   <description>Integrated Summaries of Effectiveness and Safety: Location Within the Common Technical Document</description>
   <pubDate>Mon, 20 Apr 2009 12:45 EDT</pubDate>
   <link>http://www.fda.gov/cder/guidance/8524fnl.pdf</link>
</item>
<item>
   <title>Paragraph IV Patent Certifications</title>
   <description>Office of Generic Drugs: Paragraph IV Patent Certifications (updated)</description>
   <pubDate>Mon, 20 Apr 2009 12:35 EDT</pubDate>
   <link>http://www.fda.gov/cder/ogd/ppiv.htm</link>
</item>
	</channel>
</rss>